Home / GHR Knockout Cell Lines

GHR Knockout Cell Lines

Gene: GHR

Official Full Name: growth hormone receptorprovided by HGNC

Gene Summary: This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO11301 GHR Knockout cell line (HEK293) Human GHR 1:3~1:6 Negative Online Inquiry

Background

GHR Gene Knockout Cell Lines are genetically modified cell lines designed to specifically ablate the growth hormone receptor (GHR) gene, resulting in the loss of GHR expression. This innovative product enables researchers to investigate the biological roles of growth hormone signaling and its implications in various physiological processes and disease states. By creating a cellular context devoid of GHR, these cell lines facilitate detailed studies into the mechanisms by which growth hormone influences cellular proliferation, differentiation, and metabolism.

The primary function of GHR Gene Knockout Cell Lines is to serve as a model for elucidating the complexities associated with growth hormone signaling pathways. Without the interference of GHR, researchers can more accurately assess downstream effects such as IGF-1 (Insulin-like Growth Factor 1) signaling and metabolic responses. This capability is vital for understanding conditions such as growth disorders, metabolic diseases, and cancers that may be influenced by aberrant growth hormone signaling.

The scientific importance of these cell lines extends into both research and clinical applications. They provide a powerful tool for drug testing and the identification of potential therapeutic interventions aimed at modulating growth hormone signaling. By offering a reliable in vitro model, they can accelerate the pace of research, promoting the discovery of novel biomarkers and treatment strategies in endocrinology and oncology.

Compared to traditional cell lines that express GHR, GHR Gene Knockout Cell Lines present a clear advantage by eliminating the confounding variable of GHR expression. This specificity enhances the accuracy of experimental results and ensures that findings are directly attributable to the manipulation of growth hormone pathways, thus bolstering the integrity of data obtained from such studies.

For researchers, clinicians, and biopharmaceutical companies, the value of GHR Gene Knockout Cell Lines lies in their ability to enable groundbreaking studies that pave the way for potential therapeutic advances. With these cell lines, users can confidently explore the nuances of growth hormone biology, leading to innovative solutions to complex health challenges.

Our company specializes in the development of advanced genetic models and cellular tools, bringing unparalleled expertise and innovative solutions to the life sciences field. We are committed to empowering scientists with high-quality products that facilitate cutting-edge research and clinical breakthroughs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.